This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Galectin Therapeutics Inc (GALT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 10.49M 9.36M 6.40M 5.89M
Receivables 0.00 0.00 0.00 234.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 10.69M 9.52M 6.50M 6.20M
Property, Plant & Equipment, Gross 74.00K 74.00K 321.00K 316.00K
Accumulated Depreciation & Depletion 71.00K 66.00K 315.00K 309.00K
Property, Plant & Equipment, Net 3.00K 8.00K 6.00K 7.00K
Intangibles 23.00K 30.00K 36.00K 39.00K
Other Non-Current Assets 0.00 6.00K 69.00K 59.00K
Total Non-Current Assets 26.00K 44.00K 111.00K 105.00K
Liabilities & Shareholder Equity
Total Assets 10.71M 9.56M 6.61M 6.30M
Accounts Payable 762.00K 930.00K 384.00K 125.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 73.00K 557.00K 80.00K 861.00K
Total Current Liabilities 2.49M 1.64M 2.22M 1.77M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 6.75M 6.76M 0.00 2.08M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 6.75M 6.76M 6.52M 6.22M
Total Liabilities 9.23M 8.40M 8.74M 7.99M
Preferred Stock Equity 7.33M 632.00K 632.00K 644.00K
Common Stock Equity -5.85M 533.00K -2.76M -2.34M
Common Par 18.00K 16.00K 13.00K 64.00K
Additional Paid In Capital 102.84M 80.54M 66.37M 54.02M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -101.96M -80.02M -69.14M -56.42M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -6.75M 0.00 0.00 0.00
Total Capitalization 1.48M 1.16M -2.12M -1.69M
Total Equity 1.48M 1.16M -2.12M -1.69M
Total Liabilities & Stock Equity 10.71M 9.56M 6.61M 6.30M
Total Common Shares Outstanding 18.39M 16.06M 12.92M 10.65M
Preferred Shares 1.45M 1.56M 1.56M 1.59M
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 16.87M 15.13M 11.99M 9.38M
Diluted Weighted Shares Outstanding 16.87M 15.13M 11.99M 9.38M
Number of Employees 6 5 7 6
Number of Part-Time Employees 0 0 0 0
GALT News

GALT Galectin Therapeutics Inc

Analysts Ratings for GALT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GALT ANALYST REPORT

Brokerage Partners

GALT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs